Literature DB >> 17236263

Controversy about COOPERATE ABPM trial data.

Anil Bidani.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 17236263     DOI: 10.1159/000098196

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


× No keyword cloud information.
  4 in total

1.  Combination therapy of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chronic kidney disease.

Authors:  Nina Vasavada; Rajiv Agarwal
Journal:  F1000 Med Rep       Date:  2009-06-09

2.  Uncritical acceptance of combination treatment of angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor in nondiabetic renal disease trial results.

Authors:  Karen A Griffin; Anil K Bidani
Journal:  Hypertension       Date:  2008-12-01       Impact factor: 10.190

Review 3.  The current state of RAAS blockade in the treatment of hypertension and proteinuria.

Authors:  Rigas G Kalaitzidis; George L Bakris
Journal:  Curr Cardiol Rep       Date:  2009-11       Impact factor: 2.931

4.  Design of combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor for treatment of diabetic nephropathy (VA NEPHRON-D).

Authors:  Linda F Fried; William Duckworth; Jane Hongyuan Zhang; Theresa O'Connor; Mary Brophy; Nicholas Emanuele; Grant D Huang; Peter A McCullough; Paul M Palevsky; Stephen Seliger; Stuart R Warren; Peter Peduzzi
Journal:  Clin J Am Soc Nephrol       Date:  2008-12-31       Impact factor: 8.237

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.